Congo vs Namibia: Cause of death, by non-communicable diseases, ages 5-14, male
Congo
13.3%
in 2021
Namibia
13.2%
in 2021
Congo rank
180th
Namibia rank
181st
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Congo
- Namibia
How they compare
Congo currently reports 13.3% against 13.2% in Namibia, a difference of 0.1%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Namibia ahead.
Congo ranks 180th and Namibia ranks 181st of 185 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Namibia in 2.
Head to head by decade
| Decade | Congo | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 4.7% | 1.3% | Namibia |
| 2010s | 13.1% | 8.1% | 4.9% | Congo |
| 2020s | 12.4% | 13.5% | 1.1% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Congo or Namibia?
- Congo, at 13.3% against 13.2% in Namibia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Congo and Namibia?
- 0.1%, with Congo ahead.
- How many years of comparable data are there for Congo and Namibia?
- 6 years are reported by both, from 2000 to 2021.
- How do Congo and Namibia rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Congo ranks 180th and Namibia ranks 181st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.